Laura Oliphant - Aug 17, 2021 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Role
Director
Signature
/s/ Kenneth B. Spink, Attorney-in-fact
Stock symbol
AEHR
Transactions as of
Aug 17, 2021
Transactions value $
-$92,190
Form type
4
Date filed
8/18/2021, 08:29 PM
Previous filing
Jul 23, 2021
Next filing
Oct 20, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEHR Common Stock Options Exercise $12.6K +7.5K $1.68* 7.5K Aug 17, 2021 Direct
transaction AEHR Common Stock Options Exercise $17.7K +10K +133.33% $1.77* 17.5K Aug 17, 2021 Direct
transaction AEHR Common Stock Options Exercise $10.1K +7.5K +42.86% $1.34* 25K Aug 17, 2021 Direct
transaction AEHR Common Stock Sale -$133K -25K -100% $5.30* 0 Aug 17, 2021 Direct F1
holding AEHR Common Stock 30.4K Aug 17, 2021 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEHR Non-Qualified Stock Option (right to buy) Options Exercise $0 -7.5K -75% $0.00 2.5K Aug 17, 2021 Common Stock 7.5K $1.34 Direct F2
transaction AEHR Non-Qualified Stock Option (right to buy) Options Exercise $0 -7.5K -50% $0.00 7.5K Aug 17, 2021 Common Stock 7.5K $1.68 Direct F3
transaction AEHR Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Aug 17, 2021 Common Stock 10K $1.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F2 One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
F3 One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Remarks:

Exhibit 24 - Power of Attorney